New program using CT technology helping doctors better detect lung cancer

July 9, 2015, Intermountain Medical Center

Long-time smokers and past smokers now have a more accurate way of detecting whether or not they have lung cancer thanks to a comprehensive lung cancer screening program that uses CT scan technology at Intermountain Medical Center in Salt Lake City.

The program is based on the findings of the National Lung Screening Trial, a study that compared CT scans and standard chest X-rays in detecting lung cancer. CT scans use X-rays to obtain a multiple-image scan of the entire chest, while a standard chest X-ray produces a single image of the whole chest.

Results from the study showed that patients who received CT scans had 15 to 20 percent lower risks of dying compared to those who received a standard X-ray.

"Taking results of a research study and applying them to the real world is extremely hard to do," said Denitza Blagev, MD, a pulmonologist at Intermountain Medical Center, and one of the program leads. "But the Lung Cancer Screening Program at Intermountain Medical Center is a direct result of that effort, and because of the best practices that came from this research, we were able to diagnose three people with lung cancer in the program's first 18 months."

Dr. Blagev and her colleagues recently presented their findings at the American Thoracic Society International Conference in Denver.

The program Intermountain developed was tested between September 2014 and March 2015 and initially gave CT scans to 375 patients, 272 of whom were eligible to continue in the program. Of the 272 who were eligible, 19 of their scans found evidence of malignant cancer. From those 19, 11 were confirmed malignant. Eight of the 11 were confirmed to have lung cancer, and three of the cases were considered early stage lung cancer.

"Our goal is to save every life that we can. Our results are comparable to the National Lung Screening Trial, in which it was deemed a success if they prevented just one cancer death for every 320 patients screened. The program we created from this study detected three early stage lung cancers in the fi 357 patients screened, which is incredible. "

Patients enrolled in the program were considered high risk for lung cancer. They all had a smoking history of at least 30-pack years, which is the equivalent of smoking one pack of cigarettes every day for 30 years, and were current or former smokers without any signs or symptoms of .

"Results from the National Lung Screening Trial and from our program have shown that screenings are very effective and will greatly benefit our patients going forward," said Dr. Blagev. "These results will also help our patients financially as well. As of February of this year, the Centers for Medicare and Medicaid Services issued a statement about how they will cover the cost of screenings for lung cancer."

According to Dr. Blagev, the implementation of lung cancer screenings has been challenging because of the costs and uncertainty whether the same benefits will be seen outside a research setting. But with the recent announcement from CMS regarding coverage and the results of these studies, screening is becoming more broadly available.

Explore further: Smoking a significant predictor of lung cancer recurrence in survivors

Related Stories

Smoking a significant predictor of lung cancer recurrence in survivors

May 19, 2015
In 2015, an estimated 158,040 Americans are expected to die from lung cancer, making it the leading cause of cancer death in in this country. Lung cancer screening with low-dose CT scans in high risk smokers has recently ...

Adding genetic information to risk profile of smokers improves adherence to lung cancer screening

May 18, 2015
Researchers have found that adding genetic information to a former or current smoker's clinical risk profile results in a reclassification of their risk for lung cancer in about one in four patients. Preliminary findings ...

CT scans lower lung cancer deaths, according to study

July 3, 2014
In response to a recent national study showing that CT scans in a select high-risk population lower lung cancer deaths, NewYork-Presbyterian/Weill Cornell Medical Center has launched a lung cancer screening program for those ...

CT allows nonsurgical management of some lung nodules

June 23, 2015
People who have nonsolid lung nodules can be safely monitored with annual low-dose computed tomography (CT) screening, according to a new study published online in the journal Radiology. Researchers said the findings could ...

Medicare proposes covering lung cancer screening

November 10, 2014
Medicare may soon begin paying for scans to detect lung cancer in certain current or former heavy smokers.

Early recall rates decline after second round of lung cancer screening

March 18, 2015
The German Lung Cancer Screening Intervention Trial (LUSI) shows that the early repeat scan rate for suspicious findings decreased by more than 80% with the second and subsequent low-dose computed tomography (LDCT) screens, ...

Recommended for you

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

Repurposing FDA-approved drugs can help fight back breast cancer

November 16, 2018
Screening Food and Drug Administration (FDA)-approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in ...

Traditional chemotherapy superior to new alternative for oropharyngeal cancers

November 16, 2018
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...

New 'SLICE' tool can massively expand immune system's cancer-fighting repertoire

November 15, 2018
Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system's cancer-fighting abilities, scientists are becoming expert at manipulating ...

Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds

November 15, 2018
A new study funded by Cancer Research UK and led by the University of Birmingham has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.

Anti-malaria drugs have shown promise in treating cancer, and now researchers know why

November 15, 2018
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.